Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550302 · ClinicalTrials.gov registry record · Phase 4
Superficial Cervical Plexus Block for Shoulder Pain After Lung Surgery
A Phase 4 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01550302 is a Phase 4 study that was terminated before completion, run by University of Washington. The registered enrollment target is 10 participants.
The verdict
NCT01550302, a Phase 4 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators want to know whether injecting numbing medication on the side of the neck (also called superficial cervical plexus block) can prevent or reduce shoulder pain that patients commonly experience after lung surgery. The investigators will perform the injection at the end of your surgery while the subjects are still under general anesthesia and before they wake up. The investigators will use a local anesthetic (bupivacaine or Marcaine®) that is routinely used for skin infiltration of the surgical wounds. This study is randomized and single-blind. This means that subjects will be assigned by chance (like flipping a coin) to receive either an injection with active medication (bupivacaine), or no injection at all.
Interventions
- DRUG Bupivacaine
- PROCEDURE Superficial Cervical Plexus Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01550302
The ClinicalTrials.gov registry entry for NCT01550302 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01550302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01550302 about?
NCT01550302 is a clinical study titled "Superficial Cervical Plexus Block for Shoulder Pain After Lung Surgery". The investigators want to know whether injecting numbing medication on the side of the neck (also called superficial cervical plexus block) can prevent or reduce shoulder pain that patients commonly experience after lung surgery. The investigators will perform the injection at the end of your surger...
What is the current status of trial NCT01550302?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-10. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01550302?
The interventions under investigation include: Bupivacaine (DRUG), Superficial Cervical Plexus Block (PROCEDURE).
Who is sponsoring clinical trial NCT01550302?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.